Transcutaneous oxygen monitoring. Its use in the treatment of outpatients with congenital heart disease

doi:10.1001/archpedi.139.3.288

You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

Welcome | My Account | E-mail Alerts | Access Rights | Sign In

Vol. 139 No. 3, March 1985

Archives
	•	Online Features

ARTICLE

This Article
•	Send to a friend
•	Save in My Folder
•	Save to citation manager
•	Permissions

Citing Articles
•	Contact me when this article is cited

Related Content
•	Similar articles in this journal

Transcutaneous oxygen monitoring. Its use in the treatment of outpatients with congenital heart disease

S. S. Gidding, A. Rosenthal and C. Moorehead

To validate transcutaneous Po2 (TcPo2) monitoring for outpatient use in cyanotic congenital heart disease (CCHD), TcPo2 was compared with simultaneous arterial Po2 at cardiac catheterization and with arterial Po2 obtained by puncture. Over a 40-month period, 1,493 outpatient TcPo2 determinations were made in 461 patients to diagnose the presence or absence of hypoxemia in newly referred patients and to help assess oxygen delivery in patients with known CCHD. Clinical decisions regarding the need for further diagnostic study and the adequacy of oxygen delivery were made based on these determinations.

| | |